Health and Healthcare
5864 Articles
One in 12 U.S. doctors received more than $46 million from 2013 to 2015 in payments from drug companies that…
Acadia Pharmaceuticals reported its second-quarter financial results after the markets closed on Tuesday.
Mylan released its most recent quarterly earnings report before the markets opened on Wednesday. Unfortunately, the earnings and guidance weren't…
Valeant Pharmaceuticals reported mixed second-quarter financial results before the markets opened on Tuesday.
When FibroGen released its most recent quarterly results after the markets closed on Monday, its was not the most important…
Here are four biotech stocks for which the team of analysts at Jefferies, and analysts at other firms, see big…
Horizon Pharma released a better than expected quarterly earnings report before the markets opened on Monday.
Although Agile Therapeutics stock is down year to date, it’s actually more or less doubled since January. So now might…
Zealand Pharma intends to price nearly 4 million shares at a price that will result in an initial public offering…
A blockbuster drug is about to get a chance to have even higher sales, as the FDA has expanded its…
Clementia Pharmaceuticals entered the market with a bang, with shares priced above expected price range.
Pharmaceuticals maker Pfizer reported second-quarter earnings before markets opened Tuesday, beating profit estimates by a penny a share, but coming…
No wonder there is a national problem with opioid use. A contributing factor has to be that almost 92 Americans used…
AbbVie reported better-than-expected second-quarter financial results before the markets opened on Friday.
Tetraphase Pharmaceuticals saw its shares pull back on Friday after the company announced that it has priced a secondary offering.
Our top personal finance-related articles today. Your wallet will thank you later.